This warrants further RCTs to clarify vericiguat 10 mg place in HFrEF management guidelines by conducting head-to-head comparisons or combinations with other approved HF drugs and to investigate sGC stimulators for HFpEF in large-scale adequately designed trials. The gene discussed is SGCB; the disease is hydrops fetalis.